Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.

[1]  C. Martínez-Campa,et al.  Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor α via Calmodulin* , 2004, Journal of Biological Chemistry.

[2]  B. Lefker,et al.  Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists. , 2004, Bioorganic & medicinal chemistry letters.

[3]  B. Komm,et al.  Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease , 2003 .

[4]  B. Fournier,et al.  Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands. , 2003, Journal of medicinal chemistry.

[5]  G. Mor,et al.  Interaction of the Estrogen Receptors with the Fas Ligand Promoter in Human Monocytes1 , 2003, The Journal of Immunology.

[6]  L. Moore,et al.  A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta. , 2002, Journal of medicinal chemistry.

[7]  Chris P. Miller,et al.  SERMs: evolutionary chemistry, revolutionary biology. , 2002, Current pharmaceutical design.

[8]  U. Schopfer,et al.  Toward selective ERbeta agonists for central nervous system disorders: synthesis and characterization of aryl benzthiophenes. , 2002, Journal of medicinal chemistry.

[9]  B. Katzenellenbogen,et al.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.

[10]  Ling Wang,et al.  Morphological abnormalities in the brains of estrogen receptor β knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. Park-Sarge,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Characterization of Estrogen Receptor- � (ER�) Messenger Ribonucleic Acid and Protein Expression in Rat Granulosa Cells* , 1999 .

[12]  Daugherty Cc,et al.  Raloxifene: a selective estrogen receptor modulator. , 1999 .

[13]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[14]  K E Carlson,et al.  Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. , 1999, Journal of medicinal chemistry.

[15]  P. Koza-Taylor,et al.  Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues. , 1998, Endocrinology.

[16]  M. Breckwoldt,et al.  Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. , 1998, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[17]  B. Ettinger.  Overview of Estrogen Replacement Therapy: A Historical Perspective , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[19]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[20]  John A. Katzenellenbogen,et al.  The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site , 1997, Steroids.

[21]  N. Copeland,et al.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. , 1997, Molecular endocrinology.

[22]  B. Katzenellenbogen,et al.  Editorial: A New Actor in the Estrogen Receptor Drama-Enter ER-β. , 1997, Endocrinology.

[23]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[24]  B. Komm,et al.  The distribution of estrogen receptor-β mRNA in the rat hypothalamus , 1996, Steroids.

[25]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[26]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[28]  J. Cauley,et al.  Prevalence and determinants of estrogen replacement therapy in elderly women , 1990, American journal of obstetrics and gynecology.

[29]  J. Jespersen,et al.  Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen. , 1990, American journal of obstetrics and gynecology.

[30]  J. Lombardino,et al.  Preparation and antiinflammatory activity of some nonacidic trisubstituted imidazoles. , 1974, Journal of medicinal chemistry.

[31]  E. Angerer,et al.  Synthesis and Estrogen Receptor Affinity of 2,3‐Diarylindoles , 1987, Archiv der Pharmazie.